If I told you that cancer drugs weren't selected on the basis of how a patient's biopsied cancer cells reacted to said drugs, wouldn't you say that was nuts? Today, @exscientiaAI announced the initiation of EXCYTE-1 to study the relationship between ex vivo drug response in

→ View original post on X — @nathanbenaich